Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.
Tan WK, Segal BD, Curtis MD, Baxi SS, Capra WB, Garrett-Mayer E, Hobbs BP, Hong DS, Hubbard RA, Zhu J, Sarkar S, Samant M.
Tan WK, et al. Among authors: zhu j.
Contemp Clin Trials Commun. 2022 Sep 20;30:101000. doi: 10.1016/j.conctc.2022.101000. eCollection 2022 Dec.
Contemp Clin Trials Commun. 2022.
PMID: 36186544
Free PMC article.